(No ratings)
Dr. Andrew C. Harris, MD is a pediatric oncologist in New York, NY specializing in pediatric oncology, transplant surgery and general practice. He graduated from Case Western Reserve University School of Medicine in 2005 and has 21 years of experience. Dr. Andrew C. Harris, MD is affiliated with Memorial Sloan Kettering Cancer Center.
Dr. Andrew C. Harris, MD graduated from Case Western Reserve University School of Medicine in 2005. He completed residency at Pediatrics, Cleveland Clinic. He is certified by the Board Certification: General Pediatrics and has a state license in New York.
Medical School: Case Western Reserve University School of Medicine (2005)
Residency: Pediatrics, Cleveland Clinic (2008)
Board Certification: Board Certification: General Pediatrics
Licensed In: New York
Dr. Andrew C. Harris, MD is associated with these hospitals and organizations:
Dr. Andrew C. Harris, MD appears to accept the following insurance providers: Horizon Blue Cross Blue Shield New Jersey (HMO), Magnacare, Emblem Essential, Oscar, Fidelis Medicare Advantage, Healthfirst Medicare Advantage, Healthsmart, United Healthcare, Aetna, Tricare, Oxford, Healthfirst, Straight NY Medicaid, Cigna, Qualcare, MVP, Connecticare, First Health, Multiplan/Beech Street/PHCS, World Trade Center Health Program (WTC), Blue Cross Blue Shield states outside of NY/NJ, Empire Essential, Non-Participating Plans with Out of Network Benefits, Blue Cross Blue Shield New York, Blue Cross Blue Shield Federal Employee Program, UMR, Carrum Health, Medicare Part A&B (traditional Medicare) and Blue Cross Health Plus.
According to our sources, Dr. Andrew C. Harris, MD accepts the following insurance providers:
Dr. Andrew C. Harris, MD does not have any reviews yet, be the first to leave a review of Dr. Andrew C. Harris, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Andrew C. Harris, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Incyte Corporation |
$13,941
JAKAFI $479 |
$13,462 |
||||
|---|---|---|---|---|---|---|
| CSL Behring |
$10,246
Haegarda $77 |
$10,168 |
||||
| SANOFI-AVENTIS U.S. LLC |
$6,913
REZUROCK $608 |
$6,304 |
||||
| Horizon Therapeutics plc |
$2,790
Actimmune $2,790 |
|||||
| Janssen Scientific Affairs, LLC |
$1,010
IMBRUVICA $1,010 |
|||||
| Other |
$1,837
KYMRIAH $258 |
GAMIFANT $125 |
UVADEX METHOXSALEN STERILE SOLUTION $95 |
UVADEX (METHOXSALEN) STERILE SOLUTION $37 |
Urolift - UL400 $32 |
Other $1,291 |
| Consulting Fee | $18,946 |
|---|---|
| Travel and Lodging | $11,981 |
| Food and Beverage | $3,018 |
| Honoraria | $2,790 |
Dr. Andrew C. Harris, MD has received 53 research payments totaling $93,759.
Dr. Andrew Harris is a general practice, transplant surgery, and pediatric hematology/oncology specialist in New York, NY. He attended medical school at Case Western Reserve University School of Medicine. For his residency, Dr. Harris trained at Cleveland Clinic. Clinical interests for Dr. Harris include leukemia, lymphoma, and bone marrow transplant. Dr. Harris usually is in-network for ConnectiCare, Blue California, and HealthSmart, as well as other insurance carriers. He is professionally affiliated with Memorial Sloan Kettering Cancer Center. He has an open panel in New York, NY according to Yext.